Back to results
CompletedPhase 1Phase 2

Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy

NCT01313117

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Northwestern Medical Faculty Foundation

Chicago, Illinois, United States

View on ClinicalTrials.gov
Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy — TrialFind